Clinical Trial Update: Gemtuzumab Ozogamicin With G-CSF, Cladribine, Cytarabine & Mitoxantrone for Untreated AML & High-Grade Myeloid Neoplasm [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on combining gemtuzumab ozogamicin with G-CSF, cladribine, cytarabine, and mitoxantrone in untreated AML and high-grade myeloid neoplasm (…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Gemtuzumab ozogamicin (gemtuzumab ozogamicin)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-11-04